210 related articles for article (PubMed ID: 22299825)
1. Optimisation of DMPK by the inhaled route: challenges and approaches.
Cooper AE; Ferguson D; Grime K
Curr Drug Metab; 2012 May; 13(4):457-73. PubMed ID: 22299825
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs.
Matera MG; Calzetta L; Ora J; Rogliani P; Cazzola M
Expert Opin Drug Deliv; 2021 Jul; 18(7):891-906. PubMed ID: 33412922
[No Abstract] [Full Text] [Related]
3. Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.
Tolman JA; Williams RO
Drug Dev Ind Pharm; 2010 Jan; 36(1):1-30. PubMed ID: 19640248
[TBL] [Abstract][Full Text] [Related]
4. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
5. Challenges in inhaled product development and opportunities for open innovation.
Forbes B; Asgharian B; Dailey LA; Ferguson D; Gerde P; Gumbleton M; Gustavsson L; Hardy C; Hassall D; Jones R; Lock R; Maas J; McGovern T; Pitcairn GR; Somers G; Wolff RK
Adv Drug Deliv Rev; 2011; 63(1-2):69-87. PubMed ID: 21144875
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of inhaled drugs.
Lipworth BJ
Br J Clin Pharmacol; 1996 Dec; 42(6):697-705. PubMed ID: 8971424
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.
Hu X; Yang FF; Liao YH
Curr Pharm Des; 2016; 22(17):2532-48. PubMed ID: 26818873
[TBL] [Abstract][Full Text] [Related]
8. Prediction of efficacious inhalation lung doses via the use of in silico lung retention quantitative structure-activity relationship models and in vitro potency screens.
Cooper A; Potter T; Luker T
Drug Metab Dispos; 2010 Dec; 38(12):2218-25. PubMed ID: 20823295
[TBL] [Abstract][Full Text] [Related]
9. Inhaling medicines: delivering drugs to the body through the lungs.
Patton JS; Byron PR
Nat Rev Drug Discov; 2007 Jan; 6(1):67-74. PubMed ID: 17195033
[TBL] [Abstract][Full Text] [Related]
10. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy.
Mukker JK; Singh RS; Derendorf H
Adv Drug Deliv Rev; 2015 May; 85():57-64. PubMed ID: 25770775
[TBL] [Abstract][Full Text] [Related]
12. Delivery Technologies for Orally Inhaled Products: an Update.
Moon C; Smyth HDC; Watts AB; Williams RO
AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
[TBL] [Abstract][Full Text] [Related]
13. Current approaches to the discovery of novel inhaled medicines.
Strong P; Ito K; Murray J; Rapeport G
Drug Discov Today; 2018 Oct; 23(10):1705-1717. PubMed ID: 29775668
[TBL] [Abstract][Full Text] [Related]
14. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.
Borghardt JM; Weber B; Staab A; Kloft C
AAPS J; 2015 Jul; 17(4):853-70. PubMed ID: 25845315
[TBL] [Abstract][Full Text] [Related]
15. Contemporary Formulation Development for Inhaled Pharmaceuticals.
Sou T; Bergström CAS
J Pharm Sci; 2021 Jan; 110(1):66-86. PubMed ID: 32916138
[TBL] [Abstract][Full Text] [Related]
16. Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.
Ericsson T; Fridén M; Kärrman-Mårdh C; Dainty I; Grime K
Pharm Res; 2017 Dec; 34(12):2557-2567. PubMed ID: 28685298
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting Drug Exposure after Inhalation.
Nováková A; Šíma M; Slanař O
Prague Med Rep; 2022; 123(3):129-139. PubMed ID: 36107443
[TBL] [Abstract][Full Text] [Related]
18. Inhalation Biopharmaceutics: Progress Towards Comprehending the Fate of Inhaled Medicines.
Ehrhardt C
Pharm Res; 2017 Dec; 34(12):2451-2453. PubMed ID: 29147818
[No Abstract] [Full Text] [Related]
19. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
Martin AR; Moore CP; Finlay WH
Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
